Are we ready for neoadjuvant therapy in potentially resectable pancreatic cancer?
Philip, P.A.
Oncology 25(2): 189-190; 192
2011
ISSN/ISBN: 0890-9091 PMID: 21456391 Document Number: 649399
Document emailed within 1 workday
Related Documents
Mataki, Y.; Shinchi, H.; Maemura, K.; Kurahara, H.; Kawasaki, Y.; Desaki, R.; Ueno, S.; Sakoda, M.; Iino, S.; Higashi, M.; Takao, S.; Natsugoe, S. 2013: Examination of resectable and borderline pancreatic cancer treated with neoadjuvant chemoradiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1637-1640Motoi, F.; Kawaguchi, K.; Aoki, T.; Kudo, K.; Yabuuchi, S.; Fukase, K.; Mizuma, M.; Sakata, N.; Otsutomo, S.; Morikawa, T.; Hayashi, H.; Nakagawa, K.; Okada, T.; Yoshida, H.; Naitoh, T.; Katayose, Y.; Egawa, S.; Unno, M. 2013: Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1632-1636
Miyamoto, T.; Inoue, M.; Tanemura, M.; Yamaguchi, M.; Irei, T.; Tamaru, K.; Seo, S.; Misumi, T.; Shimizu, W.; Suzuki, T.; Onoe, T.; Sudo, T.; Shimizu, Y.; Hinoi, T.; Tashiro, H. 2018: A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 88-90
Huang, L. 2018: Neoadjuvant Chemoradiotherapy Followed by Surgery versus Surgery Alone for Resectable Pancreatic Carcinoma American surgeon 84(12): e567-e574
Al-Hajeili, M.; Marshall, J.L.; Smaglo, B.G. 2016: Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal Cancer Oncology 30(1): 10-16
2015: (S021) the role of neoadjuvant stereotactic body radiation therapy in pancreatic cancer Oncology 29(4 Suppl. 1)
Nakagohri, T.; Yoneyama, Y.; Kinoshita, T.; Konishi, M.; Inoue, K.; Takahashi, S. 2008: Prognostic significance of peritoneal washing cytology in patients with potentially resectable gastric cancer Hepato-Gastroenterology 55(86-87): 1913-1915
Aziz, H.; Zeeshan, M.; Jie, T.; Maegawa, F.B. 2019: Neoadjuvant Chemoradiation Therapy Is Associated with Adverse Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer American Surgeon 85(11): 1276-1280
Chinnery, G.; Plaskett, J.; Jonas, E. 2017: Is Routine Staging Laparoscopy in Potentially Resectable Disease Justified in Gastric Cancer? a Single Unit Experience South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 55(3): 73-74
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Berlin, J.D.; Rothenberg, M. 2001: Chemotherapy for resectable and advanced pancreatic cancer Oncology 15(10): 1241-1249; 1254; Discussion: 1254-1264
Seddik, Y.; Brahmi, S.Aziz.; Afqir, S. 2019: Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study Gulf Journal of Oncology 1(30): 29-32
Katz, M.H.G.; Ahmad, S.; Nelson, H. 2013: Borderline resectable pancreatic cancer: pushing the technical limits of surgery Bulletin of the American College of Surgeons 98(1): 61-63
Shah, A.P.; Strauss, J.B.; Leslie, W.T.; Shah, A.; Mahon, B.; Abrams, R.A. 2008: Management of a patient with borderline resectable pancreatic cancer. Case report and review Oncology 22(13): 1524-1529
Nakayasu, Y.; Shiozawa, S.; Usui, T.; Kuhara, K.; Kono, T.; Shimojima, Y.; Tsuchiya, A.; Miyauchi, T.; Asaka, S.; Yamaguchi, K.; Yokomizo, H.; Shimakawa, T.; Naritaka, Y. 2018: A Case of Borderline Resectable Pancreatic Head Cancer Treated by Curative Resection after Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(13): 2306-2308
Berardi, R.; Verdecchia, L.; Scartozzi, M.; Cascinu, S. 2005: New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols Jop: Journal of the Pancreas 6(1 Suppl): 118-121
Watanabe, F.; Honda, G.; Kurata, M.; Tsuruta, K.; Tokashiki, T.; Funada, N. 2009: A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2430-2432
Goldberg, M. 2000: Multimodality therapy in surgically resectable early non-small cell lung cancer In Vivo 14(1): 51-60
Hudis, C.A.; Seidman, A.D.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Currie, V.; Moynahan, M.E.; Sklarin, N.; Fennelly, D. 1995: Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes Seminars in Oncology 22(6 Suppl 15: 18-23
Miki, T.; Kamoi, K. 2001: Neoadjuvant hormonal therapy for prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(7): 927-933